FDA advisory panel votes to recommend Aimmune peanut allergy therapy

FDA advisory panel votes to recommend Aimmune peanut allergy therapy

FDA advisory panel recommends approval of Aimmune peanut allergy therapy

By ADAM FEUERSTEIN

ADOBE

This FDA advisory panel is a pivotal moment for Aimmune Therapeutics, the biopharma company that developed the new treatment.

READ MORE